Antibody-directed natural cytotoxicity results in enhanced killing of HIV gp120-coated CEMNKR cells

被引:3
作者
Liu, M [1 ]
Roberts, RL [1 ]
Ank, BJ [1 ]
Marmet, JG [1 ]
Stiehm, ER [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,DIV ALLERGY IMMUNOL,LOS ANGELES,CA 90095
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1997年 / 83卷 / 02期
关键词
D O I
10.1006/clin.1997.4330
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular cytotoxicity may be an important defense in the control of HIV progression. In the present study antibodies were attached to peripheral blood mononuclear cells (PBMC) by exposing them to polyethylene glycol and phthalate oil in the presence of HIV human hyperimmune IVIG (HIVIG). The attachment procedure is known as ''franking'' and the resultant cytotoxicity is termed ''antibody-directed.'' The majority of the cells that are franked with attached HIVIG are CD16(+) (Fc gamma RIII), placing them in the natural killer cell population. Franking increased the cytotoxicity of PBMC from both healthy controls and HIV-seropositive patients approximately fourfold compared to conventional antibody-dependent cellular cytotoxicity using CEM cells coated with HIV gp120 antigen as targets. Use of anti-HIV monoclonal antibodies for franking was less efficient than polyclonal HIVIG. The HIVIG-franked PBMC suppressed p24 production of in vitro HIVIIIb-infected human PBMC. The ability of HIVIG to enhance and direct cytotoxicity to HIV targets may suggest a new therapeutic approach to HIV control. (C) 1997 Academic Press.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 14 条
[1]  
AHMAD A, 1994, J ACQ IMMUN DEF SYND, V7, P428
[2]   NATURAL-KILLER CELL-FUNCTION IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND RELATED DISEASES [J].
BRENNER, BG ;
DASCAL, A ;
MARGOLESE, RG ;
WAINBERG, MA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 46 (01) :75-83
[3]  
CUMMINS LM, 1991, BLOOD, V77, P1111
[4]  
JONES JF, 1980, J IMMUNOL, V125, P926
[5]  
KATZ JD, 1987, J IMMUNOL, V139, P55
[6]  
LIU M, 1995, J ACQ IMMUN DEF SYND, V9, P321
[7]  
LJUNGGREN K, 1987, J IMMUNOL, V139, P2263
[8]  
MUCHMORE AV, 1979, J IMMUNOL, V122, P1152
[9]  
SCOTTALGARA D, 1992, CLIN EXP IMMUNOL, V90, P181
[10]   DIRECTED EFFECTOR-CELLS SELECTIVELY LYSE HUMAN-TUMOR CELLS [J].
SIMONE, CB .
NATURE, 1982, 297 (5863) :234-236